Today: 9 June 2026
Browse Category

NSE:PATANJALI 20 January 2026

Sensex, Nifty slide to 3-month lows as ₹9.86 lakh crore evaporates — what traders are watching now

Sensex, Nifty slide to 3-month lows as ₹9.86 lakh crore evaporates — what traders are watching now

Sensex fell 1,065.71 points to close at 82,180.47, while Nifty 50 dropped 1.38% to 25,232.50, marking their lowest finishes in over three months. BSE-listed stocks lost about ₹9.86 lakh crore in market value. Over 490 NSE stocks hit 52-week lows. Analysts highlighted key Nifty support at 25,150–25,080 amid continued foreign selling.
20 January 2026
·····

Stock Market Today

  • TSX Penny Stocks Spotlight: Imagine Lithium, Kenorland Minerals, Torrent Capital Analysis
    June 9, 2026, 9:59 AM EDT. Imagine Lithium Inc., a debt-free junior mineral explorer with a market cap of CA$5.11 million, remains unprofitable but shows reduced losses. Kenorland Minerals Ltd., valued at CA$164.09 million, faces declining revenues and a net loss of CA$5.14 million in Q1 2026; its cash runway is under one year amid ongoing exploration. Torrent Capital Ltd., an investment firm with CA$19.47 million market cap, invests in public, private equities, and cryptocurrencies. Despite volatile markets, these TSX penny stocks reflect growth potential but carry risks due to earnings variability and economic uncertainties. Investors should weigh financial health ratings and operational progress carefully before committing.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop